[Continuation 48. Sudden hearing loss: new guidelines for diagnosis and therapy].
Michel
O
O
Klinik und Poliklinik für Hals-Nasen-Ohren-Heilkunde Universität zu Köln. Michel@uni-koeln.de
D000328:Adult; D000975:Antioxidants / Q000627:therapeutic use; D001299:Audiometry; D001781:Blood Component Removal; D000075202:Contraindications; D003937:Diagnosis, Differential; D004423:Ear / Q000002:abnormalities; D016057:Evoked Potentials, Auditory, Brain Stem; D005260:Female; D005938:Glucocorticoids / Q000008:administration & dosage / Q000627:therapeutic use; D006199:Hair Cells, Auditory, Inner; D003639:Hearing Loss, Sudden / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology / Q000628:therapy; D006320:Hearing Tests; D006438:Hemodilution; D006801:Humans; D006931:Hyperbaric Oxygenation; D008012:Lidocaine / Q000008:administration & dosage / Q000627:therapeutic use; D008297:Male; D017084:Otoacoustic Emissions, Spontaneous; D017410:Practice Guidelines as Topic; D011247:Pregnancy; D012008:Recurrence; D013997:Time Factors; D014665:Vasodilator Agents / Q000627:therapeutic use
D000975:Antioxidants; D005938:Glucocorticoids; D014665:Vasodilator Agents; D008012:Lidocaine